natgillin/translations-raw huggingface dataset:
Preparation and administration of Levetiracetam Hospira concentrate for solution for infusion
Priprava in uporaba zdravila Levetiracetam Hospira koncentrat za raztopino za infundiranje
Preparation and administration precautions
Previdnostni ukrepi pri pripravi in dajanju zdravila
Preparation and administration precautions
Previdnostni ukrepi pri pripravi in dajanju:
PREPARATION FOR INTRAVENOUS ADMINISTRATION
PRIPRAVA ZA INTRAVENSKO APLIKACIJO
Preparation for intravenous administration:
Priprava za intravensko uporabo:
Preparation for nasogastric tube or gastrostomy tube administration:
Priprava za aplikacijo preko nazogastrične sonde ali gastrostome:
PREPARATION FOR THE INTRAVENOUS ADMINISTRATION
PRIPRAVA ZA INTRAVENSKO DAJANJE
PREPARATION GUIDE
NAVODILO ZA PRIPRAVO
PREPARATION GUIDE FOR USE WITH DOCEFREZ 20 MG, POWDER AND SOLVENT FOR CONCENTRATE FOR SOLUTION FOR INFUSION
NAVODILA ZA UPORABO GLEDE PRIPRAVE KONCENTRATA ZA RAZTOPINO ZA INFUNDIRANJE DOCEFREZ 20 mg IN VEHIKLA DOCEFREZ
PREPARATION GUIDE FOR USE WITH DOCEFREZ 80 MG, POWDER AND SOLVENT FOR CONCENTRATE FOR SOLUTION FOR INFUSION
NAVODILA ZA UPORABO GLEDE PRIPRAVE KONCENTRATA ZA RAZTOPINO ZA INFUNDIRANJE DOCEFREZ 80 mg IN VEHIKLA DOCEFREZ
PREPARATION GUIDE FOR USE WITH DOCETAXEL ACCORD CONCENTRATE FOR SOLUTION FOR INFUSION
NAVODILA ZA UPORABO GLEDE PRIPRAVE KONCENTRATA ZA RAZTOPINO ZA INFUNDIRANJE DOCETAKSEL ACCORD
PREPARATION GUIDE FOR USE WITH DOCETAXEL KABI 120 mg/6 ml CONCENTRATE FOR SOLUTION FOR INFUSION
NAVODILA ZA UPORABO GLEDE PRIPRAVE KONCENTRATA ZA RAZTOPINO ZA INFUNDIRANJE ZDRAVILA DOCETAKSEL KABI 120 mg/6 ml
PREPARATION GUIDE FOR USE WITH DOCETAXEL KABI 160 mg/8 ml CONCENTRATE FOR SOLUTION FOR INFUSION
NAVODILA ZA UPORABO GLEDE PRIPRAVE KONCENTRATA ZA RAZTOPINO ZA INFUNDIRANJE ZDRAVILA DOCETAKSEL KABI 160 mg/8 ml
PREPARATION GUIDE FOR USE WITH DOCETAXEL KABI 180 mg/9 ml CONCENTRATE FOR SOLUTION FOR INFUSION
NAVODILA ZA UPORABO GLEDE PRIPRAVE KONCENTRATA ZA RAZTOPINO ZA INFUNDIRANJE ZDRAVILA DOCETAKSEL KABI 180 mg/9 ml
PREPARATION GUIDE FOR USE WITH DOCETAXEL KABI 20 mg/1 ml CONCENTRATE FOR SOLUTION FOR INFUSION
NAVODILA ZA UPORABO GLEDE PRIPRAVE KONCENTRATA ZA RAZTOPINO ZA INFUNDIRANJE ZDRAVILA DOCETAKSEL KABI 20 mg/1 ml
PREPARATION GUIDE FOR USE WITH DOCETAXEL KABI 80 mg/4 ml CONCENTRATE FOR SOLUTION FOR INFUSION
NAVODILA ZA UPORABO GLEDE PRIPRAVE KONCENTRATA ZA RAZTOPINO ZA INFUNDIRANJE ZDRAVILA DOCETAKSEL KABI 80 mg/4 ml
PREPARATION GUIDE FOR USE WITH DOCETAXEL MYLAN CONCENTRATE FOR SOLUTION FOR INFUSION
NAVODILA ZA PRIPRAVO DOCETAXEL MYLAN KONCENTRATA ZA RAZTOPINO ZA INFUNDIRANJE
PREPARATION GUIDE FOR USE WITH DOCETAXEL TEVA 20 mg CONCENTRATE AND SOLVENT FOR SOLUTION FOR INFUSION
NAVODILA ZA PRIPRAVO KONCENTRATA IN VEHIKLA ZA RAZTOPINO ZA INFUNDIRANJE DOCETAKSEL TEVA 20 mg
PREPARATION GUIDE FOR USE WITH DOCETAXEL TEVA 80 mg CONCENTRATE AND SOLVENT FOR SOLUTION FOR INFUSION
NAVODILA ZA PRIPRAVO KONCENTRATA IN VEHIKLA ZA RAZTOPINO ZA INFUNDIRANJE DOCETAKSEL TEVA 80 mg
PREPARATION GUIDE FOR USE WITH DOCETAXEL TEVA PHARMA 20 mg CONCENTRATE AND SOLVENT FOR SOLUTION FOR INFUSION
NAVODILA ZA PRIPRAVO KONCENTRATA IN VEHIKLA ZA RAZTOPINO ZA INFUNDIRANJE DOCETAXEL TEVA PHARMA 20 mg
PREPARATION GUIDE FOR USE WITH DOCETAXEL TEVA PHARMA 80 mg CONCENTRATE AND SOLVENT FOR SOLUTION FOR INFUSION
NAVODILA ZA PRIPRAVO KONCENTRATA IN VEHIKLA ZA RAZTOPINO ZA INFUNDIRANJE DOCETAXEL TEVA PHARMA 80 mg
PREPARATION GUIDE FOR USE WITH DOCETAXEL WINTHROP 160 mg/8 ml CONCENTRATE FOR SOLUTION FOR INFUSION
NAVODILA ZA UPORABO GLEDE PRIPRAVE KONCENTRATA ZA RAZTOPINO ZA INFUNDIRANJE ZDRAVILA DOCETAXEL WINTHROP 160 mg/8 ml
PREPARATION GUIDE FOR USE WITH DOCETAXEL WINTHROP 20 mg/1 ml CONCENTRATE FOR SOLUTION FOR INFUSION
NAVODILA ZA UPORABO GLEDE PRIPRAVE KONCENTRATA ZA RAZTOPINO ZA INFUNDIRANJE ZDRAVILA DOCETAXEL WINTHROP 20 mg/1 ml
PREPARATION GUIDE FOR USE WITH DOCETAXEL WINTHROP 80 mg/4 ml CONCENTRATE FOR SOLUTION FOR INFUSION
NAVODILA ZA UPORABO GLEDE PRIPRAVE KONCENTRATA ZA RAZTOPINO ZA INFUNDIRANJE ZDRAVILA DOCETAXEL WINTHROP 80 mg/4 ml
Preparation guide for use with Savene powder for concentrate and diluent for solution for infusion
Navodilo za pripravo zdravila Savene prašek za koncentrat in vehikel za raztopino za infundiranje
PREPARATION GUIDE FOR USE WITH TAXESPIRA CONCENTRATE FOR SOLUTION FOR INFUSION
NAVODILA ZA UPORABO ZDRAVILA TAXESPIRAKONCENTRAT ZA RAZTOPINO ZA INFUNDIRANJE
PREPARATION GUIDE FOR USE WITH TAXOTERE 160 mg/8 ml CONCENTRATE FOR SOLUTION FOR INFUSION
NAVODILA ZA UPORABO GLEDE PRIPRAVE KONCENTRATA ZA RAZTOPINO ZA INFUNDIRANJE ZDRAVILA TAXOTERE 160 mg/8 ml
PREPARATION GUIDE FOR USE WITH TAXOTERE 20 mg/0.5 ml CONCENTRATE FOR SOLUTION FOR INFUSION AND SOLVENT FOR TAXOTERE
NAVODILA ZA UPORABO GLEDE PRIPRAVE KONCENTRATA ZA RAZTOPINO ZA INFUNDIRANJE ZDRAVILA TAXOTERE 20 mg/0,5 ml IN VEHIKLA ZA ZDRAVILO TAXOTERE
PREPARATION GUIDE FOR USE WITH TAXOTERE 20 mg/1 ml CONCENTRATE FOR SOLUTION FOR INFUSION
NAVODILA ZA UPORABO GLEDE PRIPRAVE KONCENTRATA ZA RAZTOPINO ZA INFUNDIRANJE ZDRAVILA TAXOTERE 20 mg/ 1 ml
PREPARATION GUIDE FOR USE WITH TAXOTERE 80 mg/2 ml CONCENTRATE FOR SOLUTION FOR INFUSION AND SOLVENT FOR TAXOTERE
NAVODILA ZA UPORABO GLEDE PRIPRAVE KONCENTRATA ZA RAZTOPINO ZA INFUNDIRANJE ZDRAVILA TAXOTERE 80 mg/2 ml IN VEHIKLA ZA ZDRAVILO TAXOTERE
Preparation of 120 mg solution for infusion
Priprava 120 mg raztopine za infundiranje
Preparation of 250 mg dose of solution for infusion using the 250 mg vial
Priprava 250 mg odmerka raztopine za infundiranje iz 250 mg viale
Preparation of 250 mg dose of solution for infusion using the 500 mg vial
Priprava 250 mg odmerka raztopine za infundiranje z uporabo 500 mg viale
Preparation of 400 mg solution for infusion
Priprava 400 mg raztopine za infundiranje
Preparation of 500 mg dose of solution for infusion using the 500 mg vial
Priprava 500 mg odmerka raztopine za infundiranje z uporabo 500 mg viale
Preparation of a Refludan solution with a concentration of 2 mg/ml
Priprava raztopine Refludana v koncentraciji 2 mg/ml
Preparation of a Refludan solution with a concentration of 5 mg/ml
Priprava raztopine Refludana v koncentraciji 5 mg/mL
Preparation of a single injection
Priprava enkratne injekcije
Preparation of BLINCYTO 28 mcg/day infused over 24 hours at a rate of 10 mL/h
Priprava zdravila BLINCYTO 28 mcg/dan, infundiranega v 24 urah s hitrostjo 10 ml/h
Preparation of BLINCYTO 28 mcg/day infused over 48 hours at a rate of 5 mL/h
Priprava zdravila BLINCYTO 28 mcg/dan, infundiranega v 48 urah s hitrostjo 5 ml/h
Preparation of BLINCYTO 28 mcg/day infused over 72 hours at a rate of 3.3 mL/h
Priprava zdravila BLINCYTO 28 mcg/dan, infundiranega v 72 urah s hitrostjo 3,3 ml/h
Preparation of BLINCYTO 28 mcg/day infused over 96 hours at a rate of 2.5 mL/h
Priprava zdravila BLINCYTO 28 mcg/dan, infundiranega v 96 urah s hitrostjo 2,5 ml/h
Preparation of BLINCYTO 9 mcg/day infused over 24 hours at a rate of 10 mL/h
Priprava zdravila BLINCYTO 9 mcg/dan, infundiranega v 24 urah s hitrostjo 10 ml/h
Preparation of BLINCYTO 9 mcg/day infused over 48 hours at a rate of 5 mL/h
Priprava zdravila BLINCYTO 9 mcg/dan, infundiranega v 48 urah s hitrostjo 5 ml/h
Preparation of BLINCYTO 9 mcg/day infused over 72 hours at a rate of 3.3 mL/h
Priprava zdravila BLINCYTO 9 mcg/dan, infundiranega v 72 urah s hitrostjo 3,3 ml/h
Preparation of BLINCYTO 9 mcg/day infused over 96 hours at a rate of 2.5 mL/h
Priprava zdravila BLINCYTO 9 mcg/dan, infundiranega v 96 urah s hitrostjo 2,5 ml/h
Preparation of BLINCYTO should be:
Priprava zdravila BLINCYTO mora biti:
Preparation of Busulfan Fresenius Kabi
Priprava zdravila Busulfan Fresenius Kabi
Preparation of DepoCyte
Priprava zdravila DepoCyte
Preparation of injection/infusion
priprava injekcije/infuzije,
Preparation of Myocet
3.1 Priprava zdravila Myocet
Preparation of NeoRecormon Multidose solution
Priprava zdravila NeoRecormon večodmerne raztopine za injiciranje
Preparation of oral suspension
Priprava peroralne suspenzije
Preparation of solution for infusion
Priprava raztopine za infundiranje
Preparation of the 1 mg vial: add 1.0 ml of sterile, 9 mg/ml (0.9%) sodium chloride solution for injection to the vial containing the VELCADE powder.
1.1 Priprava 1 mg viale dodajte 1,0 ml sterilne 9 mg/ml (0,9%) raztopine natrijevega klorida za injiciranje v vialo s praškom zdravila VELCADE.
Preparation of the 3.5 mg vial: add 1.4 ml of sterile, 9 mg/ml (0.9%) sodium chloride solution for injection to the vial containing the Bortezomib Accord powder.
Priprava 3,5 mg viale: dodajte 1,4 ml sterilne 9 mg/ml (0,9%) raztopine natrijevega klorida za injiciranje v vialo s praškom zdravila Bortezomib Accord.
Preparation of the 3.5 mg vial: add 1.4 ml of sterile, 9 mg/ml (0.9%) sodium chloride solution for injection to the vial containing the Bortezomib Hospira powder.
Priprava 3,5 mg viale: dodajte 1,4 ml sterilne 9 mg/ml (0,9%) raztopine natrijevega klorida za injiciranje v vialo s praškom zdravila Bortezomib Hospira.
Preparation of the 3.5 mg vial: add 1.4 ml of sterile, 9 mg/ml (0.9%) sodium chloride solution for injection to the vial containing the Bortezomib SUN powder.
Priprava 3,5 mg viale: dodajte 1,4 ml sterilne 9 mg/ml (0,9 %) raztopine natrijevega klorida za injiciranje v vialo s praškom zdravila Bortezomib SUN.
Preparation of the 3.5 mg vial: add 1.4 ml of sterile, 9 mg/ml (0.9%) sodium chloride solution for injection to the vial containing the VELCADE powder.
1.1 Priprava 3,5 mg viale: dodajte 1,4 ml sterilne 9 mg/ml (0,9%) raztopine natrijevega klorida za injiciranje v vialo s praškom zdravila VELCADE.
Preparation of the 3.5 mg vial: add 3.5 ml of sterile, 9 mg/ml (0.9%) sodium chloride solution for injection to the vial containing the Bortezomib Accord powder.
Priprava 3,5 mg viale: dodajte 3,5 ml sterilne 9 mg/ml (0,9%) raztopine natrijevega klorida za injiciranje v vialo s praškom zdravila Bortezomib Accord.
Preparation of the 3.5 mg vial: add 3.5 ml of sterile, 9 mg/ml (0.9%) sodium chloride solution for injection to the vial containing the Bortezomib Hospira powder.
Priprava 3,5 mg viale: dodajte 3,5 ml sterilne 9 mg/ml (0,9%) raztopine natrijevega klorida za injiciranje v vialo s praškom zdravila Bortezomib Hospira.
Preparation of the 3.5 mg vial: add 3.5 ml of sterile, 9 mg/ml (0.9%) sodium chloride solution for injection to the vial containing the Bortezomib SUN powder.
Priprava 3,5 mg viale: dodajte 3,5 ml sterilne 9 mg/ml (0,9 %) raztopine natrijevega klorida za injiciranje v vialo s praškom zdravila Bortezomib SUN.
Preparation of the 3.5 mg vial: add 3.5 ml of sterile, 9 mg/ml (0.9%) sodium chloride solution for injection to the vial containing the VELCADE powder.
1.1 Priprava 3,5 mg viale: dodajte 3,5 ml sterilne 9 mg/ml (0,9%) raztopine natrijevega klorida za injiciranje v vialo s praškom zdravila VELCADE.
Preparation of the 50 mg/m2 infusion for paediatric patients >3 months of age (using a 50-mg vial)
Priprava infuzije 50 mg/m2 za pediatrične bolnike, stare > 3 mesece (z uporabo 50-mg viale)
Preparation of the 50 mg/m2 infusion for paediatric patients >3 months of age (using a 70-mg vial)
Priprava infuzije 50 mg/m2 za pediatrične bolnike, stare > 3 mesece (z uporabo 70-mg viale)
Preparation of the 50 mg/m2 infusion for paediatric patients >3 months of age (using a 70-mg vial)
Priprava infuzije 50 mg/m2 za pediatrične bolnike, stare >3 mesece (z uporabo 70-mg viale)
Preparation of the 70 mg/m2 infusion for paediatric patients >3 months of age (using a 50-mg vial)
Priprava infuzije 70 mg/m2 za pediatrične bolnike, stare > 3 mesece (z uporabo 50-mg viale)
Preparation of the 70 mg/m2 infusion for paediatric patients >3 months of age (using a 70-mg vial)
Priprava infuzije 70 mg/m2 za pediatrične bolnike, stare > 3 mesece (z uporabo 70-mg viale)
Preparation of the 70 mg/m2 infusion for paediatric patients >3 months of age (using a 70-mg vial)
Priprava infuzije 70 mg/m2 za pediatrične bolnike, stare >3 mesece (z uporabo 70-mg viale)
Preparation of the Aldurazyme Infusion (Use Aseptic Technique)
Priprava infuzije zdravila Aldurazyme (z uporabo aseptične tehnike)
Preparation of the Application Site
Priprava mesta aplikacije
Preparation of the Docetaxel Teva Pharma premix solution (10 mg docetaxel/ml)
4.1 Priprava osnovne raztopine zdravila Docetaxel Teva Pharma (10 mg docetaksela/ml)
Preparation of the Docetaxel Teva Pharma premix solution (10 mg docetaxel/ml)
Priprava osnovne raztopine zdravila Docetaxel Teva Pharma (10 mg docetaksela/ml)
Preparation of the Docetaxel Teva premix solution (10 mg docetaxel/ml)
Priprava osnovne raztopine zdravila Docetaksel Teva (10 mg docetaksela/ml)
Preparation of the infusion solution
4.2 Priprava raztopine za infundiranje
Preparation of the infusion solution
Priprava koncentrata za raztopino za infundiranje
Preparation of the infusion solution
Priprava raztopine za infundiranje
Preparation of the intravenous administration
Priprava za intravensko aplikacijo
Preparation of the intravenous administration
Priprava za intravensko uporabo
Preparation of the intravenous administration
Priprava za intravensko uporabo:
Preparation of the lesions: Before administration of Ameluz all lesions should be carefully wiped with an ethanol or isopropanol-soaked cotton pad to ensure degreasing of the skin.
Priprava lezij: pred uporabo zdravila Ameluz je treba temeljito vse lezije previdno obrisati z bombažno blazinico, navlaženo z etanolom ali izopropanolom, da se koža razmasti.
Preparation of the Lymphoseek radiolabelled solution for injection from the kit is done by the following aseptic procedure:
Priprava radiooznačene raztopine zdravila Lymphoseek na injiciranje vključuje naslednji aseptični postopek:
Preparation of the Naglazyme infusion (aseptic technique is to be used)
Priprava zdravila Naglazyme raztopine za infundiranje (po aseptičnem postopku)
Preparation of the reconstituted concentrate (VIBATIV 250 mg vial)
Priprava rekonstituiranega koncentrata (VIBATIV 250 mg viala)
Preparation of the sebelipase alfa infusion
Priprava infuzije sebelipaze alfa
Preparation of the sebelipase alfa infusion
Priprava infuzije sebelipazealfa
Preparation of the solution and administration
Priprava raztopine in dajanje
Preparation of the solution for infusion
Priprava raztopine za infundiranje
Preparation of the TAXOTERE premix solution (10 mg docetaxel/ml)
Priprava osnovne raztopine zdravila TAXOTERA (10 mg docetaksela/ml)
Preparation of the TAXOTERE premix solution (10 mg docetaxel/ml)
Priprava osnovne raztopine zdravila TAXOTERE (10 mg docetaksela/ml)
Preparation of the vaccine:
Priprava cepiva
Preparation of the Vimizim infusion
Priprava raztopine zdravila Vimizim za infundiranje
Preparation of Vimizim for patient’s weighing less than 25 kg, should not be diluted in sodium chloride 9 mg/ml (0.9 %) solution for infusion bags larger than 100 ml.
Za bolnike, ki tehtajo manj kot 25 kg, je treba uporabiti 100-ml ali manjše infuzijske vrečke z raztopino natrijevega klorida 9 mg/ml (0,9 %).
Preparations containing St John’s Wort should not be used during treatment with everolimus
V času zdravljenja z everolimusom se ne sme jemati pripravkov, ki vsebujejo šentjanževko.
Prepare a dose
Priprava odmerka
Prepare a dose
Pripravite odmerek
Prepare a dose
Pripravite odmerek.
Prepare a predilution of the veterinary medicinal product with an equal amount of water:
Pripravite predraztopino zdravila za uporabo v veterinarski medicini z enako količino vode:
Prepare alcohol wipes and sticking plasters (not supplied) if you need them.
Po potrebi pripravite alkoholne krpice in obliže (niso priloženi).
Prepare alcohol wipes and sticking plasters (not supplied) if you need them.
Pripravite alkoholne blazinice in lepljive obliže (niso priloženi), če jih potrebujete.
Prepare capsule.
Pripravite kapsulo:
Prepare each dose only when you are ready for an injection.
Vsak odmerek pripravite šele, ko ste pripravljeni na injiciranje.
Prepare for inhalation
Pripravite se za inhaliranje
Prepare injection site and position pre-filled syringe
Pripravite mesto injiciranja in nastavite napolnjeno injekcijsko brizgo
Prepare the dose:
POSEBNA NAVODILA ZA SHRANJEVANJE
Prepare the dose:
Pripravite odmerek:
Prepare the infusion solution using aseptic technique to ensure the sterility of the prepared solution.
Pri pripravljanju infuzijske raztopine je treba uporabljati aseptične tehnike, da se zagotovi sterilnost pripravljene raztopine.
Prepare the injection site
POSEBNA NAVODILA ZA SHRANJEVANJE
Prepare the injection site
Pripravite injekcijsko mesto
Prepare the injection solution: Remove the protective cap from the Luveris powder
Pripravite raztopino za injiciranje: Odstranite zaščitno kapico z viale s praškom zdravila
Prepare the injection solution: Remove the protective cap from the Luveris powder vial, pick
Pripravite raztopino za injiciranje: Odstranite zaščitno kapico z viale s praškom zdravila
Prepare the needle by partially peeling the package open from the end closest to the yellow syringe connector.
Pripravite iglo: delno odprite njeno ovojnino tako, da ga odlepite od konca, ki je najbližji rumenemu konektorju za brizgo.
Prepare the oral dispenser
Pripravite peroralni odmernik
Prepare the site
Priprava mesta
Prepare the site for an aseptic technique.
Mesto pripravimo za aseptično tehniko.
Prepare the suspension with water only.
Suspenzijo pripravljajte samo z vodo.
Prepare the syringe by partially peeling the package open from the end closest to white plunger rod.
Pripravite brizgo: delno odprite njeno ovojnino tako, da jo odlepite od konca, ki je najbližji belemu nosilcu bata.
Prepare to transfer the immunoglobulin 10% component of HyQvia by wiping each vial stopper with an alcohol swab, if directed and allow to air dry (at least 30 seconds).
Komponento z imunoglobulinom 10 % zdravila HyQvia na prenos pripravite tako, tako da obrišete zamašek vsake viale z alkoholnim tamponom, če je tako določeno, in pustite, da se posuši na zraku (vsaj 30 sekund).
Prepare to transfer the recombinant human hyaluronidase component of HyQvia by wiping each vial stopper with an alcohol swab, if directed and allow to air dry (at downward.
Komponento z rekombinantno humano hialuronidazo zdravila HyQvia na prenos pripravite tako, tako da obrišete zamašek vsake viale z alkoholnim tamponom, če je tako določeno, in pustite, da se posuši na zraku (vsaj 30 sekund).
Prepare TruScient sponges in the sterile field:
Priprava gobic s TruScient v sterilnem območju:
Prepare VPRIV as follows:
Navodila za pripravo zdravila VPRIV:
Prepare work surface
Priprava delovne površine
PREPARE YOUR CLICKJECT PEN Let your ClickJect Pen warm up.
PRIPRAVA CLICKJECT INJEKCIJSKEGA PERESNIKA Počakajte, da se ClickJect injekcijski peresnik segreje na sobno temperaturo.
Prepare your injection site
Priprava mesta za injiciranje
Prepare your pen
Priprava injekcijskega peresnika
Prepare your pen
Pripravite injekcijski peresnik
Prepare your skin.
Pripravite kožo.
Preparing Avonex Pen
Priprava napolnjenega injekcijskega peresnika Avonex Pen
Preparing for a Neupopeg injection?
Kaj moram narediti, preden si dam subkutano injekcijo Neupopega?
Preparing for an Aranesp injection?
Priprava na injiciranje zdravila Aranesp
Preparing for an Nespo injection?
Priprava na injiciranje Nespa
Preparing for your injection Note:
Priprava na injiciranje Opomba:
Preparing Humalog BASAL
Priprava zdravila Humalog BASAL
Preparing Humalog BASAL KwikPen
Priprava zdravila Humalog BASAL KwikPen
Preparing Humalog Mix25 KwikPen
Priprava zdravila Humalog Mix25 KwikPen
Preparing Humalog Mix50 KwikPen
Priprava zdravila Humalog Mix50 KwikPen
Preparing KwikPen
Predpriprava KwikPena
Preparing Liprolog Basal
Priprava zdravila Liprolog Basal
Preparing Liprolog Basal KwikPen
Priprava zdravila Liprolog Basal KwikPen
Preparing Liprolog Mix25 KwikPen
Priprava zdravila Liprolog Mix25 KwikPen
Preparing Liprolog Mix50 KwikPen
Priprava zdravila Liprolog Mix50 KwikPen
Preparing the 13Carbon-urea solution
Pripravljanje raztopine 13ogljikove sečnine
Preparing the Altera Nebuliser to take your Cayston
Priprava nebulatorja Altera za uporabo zdravila Cayston
Preparing the Cosentyx pre-filled syringe ready for use
Priprava napolnjene injekcijske brizge z zdravilom Cosentyx na injiciranje
Preparing the dose:
Priprava odmerka:
Preparing the Enbrel dose for injection using the “dose preparation guide” (underside of the dose tray)
Priprava odmerka zdravila Enbrel za injiciranje s pomočjo “vodila za pripravo odmerka” (na spodnji strani podstavka)
Preparing the Humira dose for injection
Priprava odmerka zdravila Humira za injiciranje
Preparing the infusion
Priprava infuzije
Preparing the infusion
Priprava raztopine za infundiranje
Preparing the infusion:
Priprava raztopine za infundiranje:
Preparing the Instanyl nasal spray
Priprava pršila za nos Instanyl
Preparing the medicine
Priprava zdravila
PREPARING THE MEDICINE
PRIPRAVLJANJE ZDRAVILA
Preparing the nasal spray for use You must prepare the nasal spray:
Priprava pršila za nos za uporabo Pršilo za nos morate pripraviti:
Preparing the new pre-filled pen for use – releasing air (priming)
Pripravljanje novega napolnjenega injekcijskega peresnika za uporabo – sproščanje zraka (priprava)
Preparing the syringe and needle for injection
Priprava brizge in igle na injiciranje
Preparing the syringe and needle for injection
Priprava injekcijske brizge in igle za injiciranje
Preparing the syringe for use
Pripravljanje injekcijske brizge za uporabo
Preparing to lose weight
Priprave na izgubo telesne mase
Preparing to take EXUBERA
Kako se pripravite, da boste vzeli zdravilo EXUBERA
Preparing your Aerivio Spiromax
Priprava zdravila Aerivio Spiromax
Preparing your Aerivio Spiromax
Priprava zdravila Airexar Spiromax
Preparing your Levemir FlexPen
Priprava injekcijskega peresnika Levemir FlexPen
Preparing your Levemir FlexTouch pen
Priprava injekcijskega peresnika Levemir FlexTouch
Preparing your NovoRapid FlexPen
Priprava injekcijskega peresnika NovoRapid FlexPen
Preparing your NovoRapid FlexTouch pen
Priprava injekcijskega peresnika NovoRapid FlexTouch
Prephase
Predhodna faza
Prephase DEX 10 mg/m2 oral, days 1-5; CP 200 mg/m2 i.v., days 3, 4, 5; MTX
predhodna faza DEX 10 mg/m2 peroralno, 1.-5. dan; CP 200 mg/m2 i.v., 3., 4., 5. dan;
Preprinted carton box 1 x 20 ml, 1 x 100 ml and 1 x 240 ml
Vnaprej tiskana kartonska škatla 1 x 20 ml, 1 x 100 ml in 1 x 240 ml
Preprinted carton box 1 x 20 ml, 1 x 100 ml or 240 ml Vial label 100 ml and 240 ml
Vnaprej tiskana kartonska škatla 1 x 20 ml, 1 x 100 ml in 1 x 240 ml Nalepka na viali 100 ml, in 240 ml
Prequenza Te
Prequenza-Te
PRES has been reported in association with Stivarga treatment (see section 4.8).
V povezavi z zdravljenjem z zdravilom Stivarga so poročali o PRES (glejte poglavje 4.8).
PRES is a rare, often reversible, rapidly evolving neurological condition, which can present with seizure, hypertension, headache, lethargy, confusion, blindness, and other visual and neurological disturbances.
PRES je redka, pogosto reverzibilna nevrološka motnja, ki se razvije hitro in se lahko kaže z epileptičnimi napadi, hipertenzijo, glavoboli, letargijo, zmedenostjo, slepoto in drugimi motnjami vida ter nevrološkimi motnjami.
PRES should be considered in any patient presenting with seizures, headache, visual disturbances, confusion or altered mental function.
PRES je treba upoštevati pri katerem koli bolniku, ki se mu pojavijo krči, glavobol, motnje vida, zmedenost ali motnje zavesti.
PRES was not reported in the pivotal Phase III study of MCRC patients.
V ključni študiji III. faze pri bolnikih mKRR niso zabeležili primerov PRES.
PRES was not reported in the pivotal phase III study of MCRC patients.
V ključni študiji III. faze pri bolnikih mKRR niso zabeležili sindroma posteriorne reverzibilne encefalopatije (PRES – posterior reversible encephalopathy syndrome).
PRES, also known as RPLS, has been reported in patients treated with lenvatinib (<1%; see section 4.8, Description of selected adverse reactions).
O sindromu posteriorne reverzibilne encefalopatije (posterior reversible encephalopathy syndrome oziroma PRES, znan tudi kot RPLS) so poročali pri bolnikih, zdravljenih z lenvatinibom (<1 %; glejte poglavje 4.8, Opis izbranih neželenih učinkov).
Prescriber checklist
Kontrolni seznam za predpisovalca
Prescriber Guide
Navodilo za predpisovalca
PRESCRIBER INFORMATION
INFORMACIJE O PREDPISOVALCU